380 related articles for article (PubMed ID: 7642925)
1. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
Tomasek J; Rayan GM
J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
[TBL] [Abstract][Full Text] [Related]
2. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptors in Dupuytren's contracture.
Pagnotta A; Specchia N; Greco F
J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
[TBL] [Abstract][Full Text] [Related]
5. Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
Verjee LS; Midwood K; Davidson D; Eastwood M; Nanchahal J
J Cell Physiol; 2010 Sep; 224(3):681-90. PubMed ID: 20432463
[TBL] [Abstract][Full Text] [Related]
6. Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts.
Rayan GM; Tomasek JJ
Tissue Cell; 1994 Oct; 26(5):747-56. PubMed ID: 9437248
[TBL] [Abstract][Full Text] [Related]
7. Intracellular actin as a marker for myofibroblasts in vitro.
Foo IT; Naylor IL; Timmons MJ; Trejdosiewicz LK
Lab Invest; 1992 Dec; 67(6):727-33. PubMed ID: 1460863
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel.
Bisson MA; Beckett KS; McGrouther DA; Grobbelaar AO; Mudera V
J Hand Surg Am; 2009; 34(6):1102-10. PubMed ID: 19505772
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro.
Rayan GM; Parizi M; Tomasek JJ
J Hand Surg Am; 1996 Nov; 21(6):1065-70. PubMed ID: 8969433
[TBL] [Abstract][Full Text] [Related]
10. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
[TBL] [Abstract][Full Text] [Related]
11. Dupuytren's fibroblast contractility by sphingosine-1-phosphate is mediated through non-muscle myosin II.
Komatsu I; Bond J; Selim A; Tomasek JJ; Levin LS; Levinson H
J Hand Surg Am; 2010 Oct; 35(10):1580-8. PubMed ID: 20888494
[TBL] [Abstract][Full Text] [Related]
12. An insight into Dupuytren's contracture.
Murrell GA
Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
[TBL] [Abstract][Full Text] [Related]
13. Expression of a novel gene, MafB, in Dupuytren's disease.
Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J
J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
[TBL] [Abstract][Full Text] [Related]
14. The myofibroblast in Dupuytren's contracture.
Rudolph R; Vande Berg J
Hand Clin; 1991 Nov; 7(4):683-92; discussion 693-4. PubMed ID: 1769990
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
Ulrich D; Ulrich F; Piatkowski A; Pallua N
Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
[TBL] [Abstract][Full Text] [Related]
16. Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence.
Degreef I; De Smet L; Sciot R; Cassiman JJ; Tejpar S
Clin Orthop Relat Res; 2009 Mar; 467(3):838-45. PubMed ID: 18958538
[TBL] [Abstract][Full Text] [Related]
17. Fibronectin filaments and actin microfilaments are organized into a fibronexus in Dupuytren's diseased tissue.
Tomasek JJ; Haaksma CJ
Anat Rec; 1991 Jun; 230(2):175-82. PubMed ID: 1867394
[TBL] [Abstract][Full Text] [Related]
18. Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren's contracture.
Satish L; O'Gorman DB; Johnson S; Raykha C; Gan BS; Wang JH; Kathju S
Cell Stress Chaperones; 2013 Jul; 18(4):397-404. PubMed ID: 23292503
[TBL] [Abstract][Full Text] [Related]
19. The effect of interferon-alpha2b on an in vitro model Dupuytren's contracture.
Sanders JL; Dodd C; Ghahary A; Scott PG; Tredget EE
J Hand Surg Am; 1999 May; 24(3):578-85. PubMed ID: 10357539
[TBL] [Abstract][Full Text] [Related]
20. Cellular structure and biology of Dupuytren's disease.
Tomasek JJ; Vaughan MB; Haaksma CJ
Hand Clin; 1999 Feb; 15(1):21-34. PubMed ID: 10050239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]